We have adapted, implemented and trained the Learned Primal Dual algorithm suggested by Adler and Öktem and evaluated its performance in reconstructing projection data from our PET scanner. Learned Primal Dual reconstructions are compared to Maximum Likelihood Expectation Maximisation (MLEM) reconstructions. Different strategies for training are also compared. Whenever the noise level of the data to reconstruct is sufficiently represented in the training set, the Learned Primal Dual algorithm performs well on the recovery of the activity concentrations and on noise reduction as compared to MLEM. The algorithm is also shown to be robust against the appearance of artefacts, even when the images that are to be reconstructed present features were not present in the training set. Once trained, the algorithm reconstructs images in few seconds or less.
27 March 2023 in IEEE Transactions on Biomedical Engineering
Objective: Effective dosing of anticoagulants aims to prevent blood clot formation while avoiding hemorrhages. This complex task is challenged by several disturbing factors and drug-effect uncertainties, requesting frequent monitoring and adjustment. Biovariability in drug absorption and action further complicates titration and calls for individualized strategies. In this paper, we propose an adaptive closed-loop control algorithm to assist in warfarin therapy management. Methods: The controller was designed and tested in silico using an established pharmacometrics model of warfarin, which accounts for inter-subject variability. The control algorithm is an adaptive Model Predictive Control (a-MPC) that leverages a simplified patient model, whose parameters are updated with a Bayesian strategy. Performance was quantitatively evaluated in simulations performed on a population of virtual subjects against an algorithm reproducing medical guidelines (MG) and an MPC controller available in the literature (l-MPC). Results: The proposed a-MPC significantly (p $< $ 0.05) lowers rising time (2.8 vs. 4.4 and 11.2 days) and time out of range (3.3 vs. 7.2 and 12.9 days) with respect to both MG and l-MPC, respectively. Adaptivity grants a significantly (p $< $ 0.05) lower number of subjects reaching unsafe INR values compared to when this feature is not present (8.9% vs.15% of subjects presenting an overshoot outside the target range and 0.08% vs. 0.28% of subjects reaching dangerous INR values). Conclusion: The a-MPC algorithm improve warfarin therapy compared to the benchmark therapies. Significance: This in-silico validation proves effectiveness of the a-MPC algorithm for anticoagulant administration, paving the way for clinical testing.
The organisation of care at diabetes outpatient clinics is typically different from that delivered by general practitioners, it is thus of interest to assess whether there is also a difference in the predictive power of heart failure hospitalisation risk scores developed independently for each subpopulation. To such a purpose, a diabetes outpatient clinic dataset and a primary care dataset were considered. A Cox proportional hazard model, an accelerated failure time model, a logistic regression, a random forest, and a K-nearest neighbours model were trained in each dataset and tested on both. The UK Prospective Diabetes Study (UKPDS) risk engine was used as benchmark. Results show that models developed using primary care data performed well on the corresponding test set but poorly when used in the diabetes outpatient clinic setting (best C-Index = 0.759vs. 0.615, best AUROC = 0.757vs. 0.598). Models trained on the diabetes outpatient clinic data performed well on the corresponding test set, and their predictive power in the primary care setting was not statistically different from the one of models developed using primary care data (best C-Index = 0.814 vs 0.740, best AUROC = 0.812 vs 0.750). In both settings UKPDS had lower predictive power than the best newly-developed models. Different care setting led to a difference in the predictive power of heart failure hospitalisation risk scores that depended on both the data used for training and the methodological approach chosen. This suggests the need to consider these factors when applying risk scores to a target population where the expected incidence of the outcome and the distribution of baseline covariates differ from those of the population for which scores were proposed.